Enveric Biosciences(ENVB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENVB Enveric Biosciences

休市中 11-13 16:00:00 EST

1.52

+0.00

-0.33%

盘后1.46

-0.05-3.63%

18:41 EST

最高1.57	最低1.51	成交量1.76万
今开1.52	昨收1.52	日振幅4.09%
总市值678.10万	流通市值657.19万	总股本447.59万
成交额2.68万	换手率0.41%	流通股本433.79万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENVB","market":"US","secType":"STK","nameCN":"Enveric Biosciences","latestPrice":1.515,"timestamp":1794603600000,"preClose":1.52,"halted":0,"volume":17583,"hourTrading":{"tag":"盘后","latestPrice":1.46,"preClose":1.515,"latestTime":"18:41 EST","volume":197,"amount":288.13,"timestamp":1794613270643,"change":-0.055,"changeRate":-0.036304,"amplitude":0.036304},"delay":0,"changeRate":-0.003289473684210602,"floatShares":4337900,"shares":4475884,"eps":-7.485814,"marketStatus":"休市中","change":-0.005,"latestTime":"11-13 16:00:00 EST","open":1.52,"high":1.5721,"low":1.51,"amount":26778.363927,"amplitude":0.040855,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.485814,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.52,"postHourTrading":{"tag":"盘后","latestPrice":1.46,"preClose":1.515,"latestTime":"18:41 EST","volume":197,"amount":288.13,"timestamp":1794613270643,"change":-0.055,"changeRate":-0.036304,"amplitude":0.036304},"volumeRatio":0.7935068110713315,"impliedVol":6.7116,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ENVB","defaultTab":"news","newsList":[{"id":"1132650418","title":"Enveric Biosciences启动先导神经塑形剂候选药物EB-003的研究性新药（IND）申报所需基因毒性研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1132650418","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132650418?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:01","pubTimestamp":1780401688,"startTime":"0","endTime":"0","summary":"Enveric Biosciences已正式启动其先导神经塑形剂候选药物EB-003的研究性新药（IND）申报所需的关键基因毒性研究。这项进展标志着该候选药物在向临床开发阶段迈进的过程中，迈出了重要的监管准备步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152538362","title":"Enveric Biosciences 公布其先导神经塑原候选药物 EB-003 光毒性分析取得积极临床前结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1152538362","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152538362?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:01","pubTimestamp":1779192107,"startTime":"0","endTime":"0","summary":"Enveric Biosciences 近日宣布，其在研的先导神经塑原候选药物 EB-003 的光毒性分析取得了积极的临床前研究结果。该分析旨在评估药物在光照条件下对皮肤的潜在毒性影响，是药物开发中安全性评价的关键环节。初步数据显示，EB-003 在此项分析中表现出良好的安全性特征，未引发显著的光毒性反应。这一积极结果为该候选药物的后续临床开发路径提供了重要的支持数据，增强了其作为潜在治疗方案的可行性。公司表示，将继续推进 EB-003 的临床前研究，为未来进入临床试验阶段奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187912495","title":"Enveric Biosciences公司宣布其EB-003成为首个选择性靶向5-HT2A与5-HT1B受体的已知化合物","url":"https://stock-news.laohu8.com/highlight/detail?id=1187912495","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187912495?lang=zh_cn&edition=full","pubTime":"2026-05-19 20:01","pubTimestamp":1779192085,"startTime":"0","endTime":"0","summary":"Enveric Biosciences公司披露，其候选药物EB-003已成为首个已知能选择性同时作用于5-HT2A和5-HT1B受体的化合物。这一发现标志着该公司在神经精神疾病治疗领域的研发取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518046279","title":"Enveric Biosciences, Inc.盘中异动 股价大跌6.04%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518046279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518046279?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:50","pubTimestamp":1741614649,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时50分，Enveric Biosciences, Inc.股票出现波动，股价快速下挫6.04%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2772.41%、624.18%、107.11%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215049abf303b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215049abf303b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161389","title":"Enveric Biosciences, Inc.盘中异动 早盘股价大跌7.14%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517161389?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:59","pubTimestamp":1741273153,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时59分，Enveric Biosciences, Inc.股票出现波动，股价快速下跌7.14%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Alx Oncology Holdings Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1403.46%、570.37%、68.21%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Aeon Biopharma, Inc.、Plus Therapeutics, Inc.，振幅分别为100.00%、41.05%、33.60%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225913a26297a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225913a26297a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516267784","title":"Enveric Biosciences, Inc.盘中异动 急速跳水5.77%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516267784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516267784?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:38","pubTimestamp":1741099138,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时38分，Enveric Biosciences, Inc.股票出现波动，股价快速下挫5.77%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1101.58%、1094.29%、429.22%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.，振幅分别为37.67%、22.25%、19.21%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223859a25f0704&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223859a25f0704&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516663443","title":"Enveric Biosciences, Inc.股价重挫10.00% 市值跌48.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516663443?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:35","pubTimestamp":1741012501,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时35分，Enveric Biosciences, Inc.股票出现异动，股价快速下跌10.00%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.16%、30.52%、29.09%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.，振幅分别为21.22%、19.25%、15.49%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223501a25d40ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223501a25d40ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514532024","title":"Enveric Biosciences, Inc.盘中异动 早盘股价大涨25.47%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514532024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514532024?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753163,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Enveric Biosciences, Inc.股票出现异动，股价大幅拉升25.47%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223243a2580191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223243a2580191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514856610","title":"Enveric Biosciences, Inc.盘中异动 早盘快速上涨187.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856610?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580347,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Enveric Biosciences, Inc.股票出现异动，股价急速拉升187.29%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2837.58%、119.45%、90.45%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为35.59%、16.86%、14.35%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223227a254f6ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223227a254f6ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2514013027","title":"Enveric Biosciences, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514013027?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:06","pubTimestamp":1740496000,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时06分，Enveric Biosciences, Inc.股票出现异动，股价急速跳水5.11%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230640989254bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230640989254bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513372038","title":"Enveric Biosciences, Inc.盘中异动 快速上涨5.88%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513372038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513372038?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407531,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，Enveric Biosciences, Inc.股票出现波动，股价快速上涨5.88%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 涨幅较大，Aditxt, Inc.、Biodexa Pharmaceuticals Plc、Acurx Pharmaceuticals, Inc.较为活跃，换手率分别为40.26%、24.06%、17.71%，振幅较大的相关个股有Gossamer Bio, Inc.、Summit Therapeutics Inc.、Estrella Immunopharma, Inc.，振幅分别为14.69%、12.61%、12.38%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223211a2521474&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223211a2521474&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512431096","title":"Enveric Biosciences, Inc.盘中异动 快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512431096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512431096?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:59","pubTimestamp":1739998793,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时59分，Enveric Biosciences, Inc.股票出现异动，股价快速下跌5.06%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Editas Medicine, Inc.、Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为720.59%、261.85%、236.83%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Surrozen Inc C/Wts 01/08/2031 、Osr Holdings, Inc.，振幅分别为288.38%、280.70%、160.77%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022004595496290a9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022004595496290a9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511944756","title":"Enveric Biosciences, Inc.盘中异动 大幅上涨5.03%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511944756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511944756?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:35","pubTimestamp":1739547319,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时35分，Enveric Biosciences, Inc.股票出现波动，股价急速上涨5.03%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214233519abcf1526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214233519abcf1526&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511152526","title":"Enveric Biosciences, Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511152526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511152526?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:35","pubTimestamp":1739457345,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时35分，Enveric Biosciences, Inc.股票出现异动，股价急速下跌5.06%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Dominari Holdings Inc.涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为999.04%、839.93%、96.16%，振幅较大的相关个股有Edesa Biotech, Inc.、Fibrobiologics, Inc.、Pliant Therapeutics, Inc.，振幅分别为25.80%、16.76%、13.60%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132235459621bce1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132235459621bce1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510325793","title":"Enveric Biosciences, Inc.盘中异动 临近午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510325793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510325793?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:35","pubTimestamp":1739291730,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时35分，Enveric Biosciences, Inc.股票出现波动，股价快速下跌5.00%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.45%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2912.75%、1279.97%、430.25%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为96.94%、59.46%、58.60%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212003530a24215f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212003530a24215f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510863250","title":"Enveric Biosciences, Inc.盘中异动 早盘股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510863250?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:39","pubTimestamp":1739198366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时39分，Enveric Biosciences, Inc.股票出现波动，股价大幅跳水5.42%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nls Pharmaceutics Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1895.47%、1016.68%、683.31%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Invivyd, Inc.，振幅分别为50.12%、34.46%、29.90%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223926a240a40f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223926a240a40f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509722375","title":"Enveric Biosciences, Inc.盘中异动 急速下挫5.95%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509722375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509722375?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:28","pubTimestamp":1738949335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日01时28分，Enveric Biosciences, Inc.股票出现波动，股价快速下挫5.95%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。Enveric 还在开发 EB-002，一种活性代谢物 psilocin 的下一代合成前药，正被研究用于治疗精神疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208012856987dcc66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208012856987dcc66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509725932","title":"Enveric Biosciences, Inc.盘中异动 快速下跌5.78%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509725932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509725932?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:37","pubTimestamp":1738852662,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时37分，Enveric Biosciences, Inc.股票出现波动，股价急速下跌5.78%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Transcode Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4288.68%、401.67%、118.76%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Azitra Inc，振幅分别为55.65%、35.22%、29.47%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223742abc4d652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223742abc4d652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508576264","title":"Enveric Biosciences, Inc.盘中异动 早盘股价大跌6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508576264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508576264?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:33","pubTimestamp":1738679631,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时33分，Enveric Biosciences, Inc.股票出现异动，股价快速跳水6.03%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Azitra Inc、Evaxion Biotech As、Invivyd, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为926.54%、693.83%、187.53%，振幅较大的相关个股有Azitra Inc、Invivyd, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为35.91%、19.81%、19.74%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042233519617d7ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042233519617d7ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149660","title":"Enveric Biosciences, Inc.盘中异动 早盘快速下挫8.13%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149660?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593310,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Enveric Biosciences, Inc.股票出现波动，股价快速跳水8.13%。Enveric Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为350.94%、301.23%、139.52%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、26.50%。Enveric Biosciences, Inc.公司简介：Enveric Biosciences Inc是一家生物技术公司，致力于开发新型神经质体小分子疗法，用于治疗抑郁症、焦虑症和成瘾性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322351098796f95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322351098796f95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENVB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.enveric.com","stockEarnings":[{"period":"1week","weight":0.0639},{"period":"1month","weight":0.1058},{"period":"3month","weight":-0.013},{"period":"6month","weight":-0.3267},{"period":"1year","weight":-0.7225},{"period":"ytd","weight":-0.5826}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Enveric Biosciences, Inc.于1994年2月根据特拉华州法律成立。Enveric Biosciences是一家生物技术公司，致力于开发新一代小分子神经可塑性疗法，以满足精神和神经系统疾病领域尚未满足的医疗需求。该公司利用其独特的药物发现平台和不断增长的专利保护化学结构库，推进一系列旨在促进神经可塑性且不产生致幻作用的新型化合物的研发。其主要候选药物EB-003是一种旨在选择性地与5-HT2A和5-HT1B受体结合的化合物，有望提供快速起效、持久的抗抑郁和抗焦虑作用，适用于门诊治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.176137},{"month":2,"riseRate":0.333333,"avgChangeRate":0.037546},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.164315},{"month":4,"riseRate":0.333333,"avgChangeRate":0.030879},{"month":5,"riseRate":0.222222,"avgChangeRate":0.034325},{"month":6,"riseRate":0.666667,"avgChangeRate":0.000876},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.053788},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.107154},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.083367},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.220918},{"month":11,"riseRate":0.444444,"avgChangeRate":1.623291},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.152619}],"exchange":"NASDAQ","name":"Enveric Biosciences","nameEN":"Enveric Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Enveric Biosciences(ENVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Enveric Biosciences(ENVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Enveric Biosciences,ENVB,Enveric Biosciences股票,Enveric Biosciences股票老虎,Enveric Biosciences股票老虎国际,Enveric Biosciences行情,Enveric Biosciences股票行情,Enveric Biosciences股价,Enveric Biosciences股市,Enveric Biosciences股票价格,Enveric Biosciences股票交易,Enveric Biosciences股票购买,Enveric Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Enveric Biosciences(ENVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Enveric Biosciences(ENVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}